Codexis Inc
CDXS2.828USD
+0.138+5.12%
交易中 （美东）报价延迟15分钟
234.25M总市值
亏损市盈率 TTM
关于 Codexis Inc 公司
Codexis, Inc. 是一家酶工程公司。该公司正在利用其 CodeEvolver 技术平台来发现、开发、增强和商业化新型高性能酶和其他类别的蛋白质。该公司利用其 CodeEvolver 技术平台开发优化的酶，一些制药公司使用这些酶来降低成本并提高小分子疗法制造工艺的效率和生产力。该公司正在开发其酶催化寡核苷酸合成 (ECO Synthesis) 制造平台，以便通过酶促途径大规模生产 RNA 干扰 (RNAi) 疗法。该公司还使用 CodeEvolver 平台技术开发用于合成核酸（例如 DNA/RNA）的酶，包括其 ECO Synthesis 制造平台中使用的酶，其酶有望提供其在制药制造中提供的许多相同优势。
公司简介
公司代码CDXS
公司名称Codexis Inc
上市日期Apr 22, 2010
CEODr. Stephen G. Dilly, Ph.D.
员工数量188
证券类型Ordinary Share
年结日Apr 22
公司地址200 Penobscot Dr
城市REDWOOD CITY
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编94063
电话16504218100
网址https://www.codexis.com/
公司代码CDXS
上市日期Apr 22, 2010
CEODr. Stephen G. Dilly, Ph.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. David V. Smith
Mr. David V. Smith
Lead Independent Director
Lead Independent Director
194.28K
+26.74%
Mr. Kevin Norrett
Mr. Kevin Norrett
Chief Operating Officer
Chief Operating Officer
160.27K
+10.73%
Mr. Dennis P. Wolf
Mr. Dennis P. Wolf
Independent Director
Independent Director
147.90K
+38.33%
Dr. Rahul Singhvi
Dr. Rahul Singhvi
Independent Director
Independent Director
132.05K
+45.00%
Dr. Esther Martinborough, Ph.D.
Dr. Esther Martinborough, Ph.D.
Independent Director
Independent Director
129.04K
+46.54%
Ms. Cynthia Collins
Ms. Cynthia Collins
Independent Director
Independent Director
112.16K
+57.58%
Dr. Alison Moore, Ph.D.
Dr. Alison Moore, Ph.D.
Executive Vice President, Chief Technical Officer
Executive Vice President, Chief Technical Officer
98.70K
-43.79%
Dr. Raymond De Vre, Ph.D.
Dr. Raymond De Vre, Ph.D.
Independent Director
Independent Director
88.83K
+85.66%
Mr. Christos Richards
Mr. Christos Richards
Independent Director
Independent Director
85.13K
+92.83%
Ms. Georgia L. Erbez
Ms. Georgia L. Erbez
Chief Financial Officer
Chief Financial Officer
76.88K
+53.75%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. David V. Smith
Mr. David V. Smith
Lead Independent Director
Lead Independent Director
194.28K
+26.74%
Mr. Kevin Norrett
Mr. Kevin Norrett
Chief Operating Officer
Chief Operating Officer
160.27K
+10.73%
Mr. Dennis P. Wolf
Mr. Dennis P. Wolf
Independent Director
Independent Director
147.90K
+38.33%
Dr. Rahul Singhvi
Dr. Rahul Singhvi
Independent Director
Independent Director
132.05K
+45.00%
Dr. Esther Martinborough, Ph.D.
Dr. Esther Martinborough, Ph.D.
Independent Director
Independent Director
129.04K
+46.54%
Ms. Cynthia Collins
Ms. Cynthia Collins
Independent Director
Independent Director
112.16K
+57.58%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
暂无数据
地区USD
名称
营收
占比
EMEA
3.92M
51.96%
America
2.09M
27.68%
APAC
1.54M
20.36%
业务
地区
暂无数据
股东统计
更新时间: 7月12日 周六
更新时间: 7月12日 周六
持股股东
股东类型
持股股东
持股股东
占比
Opaleye Management Inc.
14.79%
Casdin Capital, LLC
9.78%
BlackRock Institutional Trust Company, N.A.
7.52%
The Vanguard Group, Inc.
5.70%
Fidelity Management & Research Company LLC
5.20%
Other
57.00%
持股股东
持股股东
占比
Opaleye Management Inc.
14.79%
Casdin Capital, LLC
9.78%
BlackRock Institutional Trust Company, N.A.
7.52%
The Vanguard Group, Inc.
5.70%
Fidelity Management & Research Company LLC
5.20%
Other
57.00%
股东类型
持股股东
占比
Investment Advisor
35.15%
Hedge Fund
29.92%
Investment Advisor/Hedge Fund
21.10%
Individual Investor
2.84%
Research Firm
1.29%
Pension Fund
0.23%
Bank and Trust
0.20%
Insurance Company
0.01%
Other
9.25%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
284
75.54M
91.18%
-4.83M
2025Q1
321
69.35M
83.91%
-9.24M
2024Q4
334
67.97M
82.44%
-9.17M
2024Q3
341
66.67M
93.65%
-3.04M
2024Q2
355
56.24M
79.41%
-16.85M
2024Q1
368
57.66M
81.73%
-20.93M
2023Q4
384
58.98M
84.48%
-18.95M
2023Q3
392
59.46M
85.28%
-19.41M
2023Q2
387
64.66M
96.86%
-12.85M
2023Q1
391
64.45M
97.75%
-12.56M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Opaleye Management Inc.
12.24M
14.78%
+250.00K
+2.08%
Jun 16, 2025
Casdin Capital, LLC
8.10M
9.78%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
6.23M
7.52%
+27.40K
+0.44%
Mar 31, 2025
The Vanguard Group, Inc.
4.72M
5.7%
+261.14K
+5.85%
Mar 31, 2025
Fidelity Management & Research Company LLC
4.31M
5.2%
+50.27K
+1.18%
Mar 31, 2025
abrdn Inc.
606.29K
0.73%
+97.67K
+19.20%
Mar 31, 2025
Telemark Asset Management, LLC
3.00M
3.62%
--
--
Mar 31, 2025
Nantahala Capital Management, LLC
2.83M
3.42%
-11.04K
-0.39%
Mar 31, 2025
Columbia Threadneedle Investments (US)
2.53M
3.06%
+135.06K
+5.63%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.93M
2.32%
+69.77K
+3.76%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
Invesco NASDAQ Future Gen 200 ETF
0.48%
Inspire Small/Mid Cap ESG ETF
0.18%
iShares Micro-Cap ETF
0.05%
Federated Hermes MDT Small Cap Core ETF
0.05%
Fidelity Enhanced Small Cap ETF
0.03%
Invesco Nasdaq Biotechnology ETF
0.02%
iShares Biotechnology ETF
0.02%
ProShares Ultra Nasdaq Biotechnology
0.02%
iShares Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
查看更多
Invesco NASDAQ Future Gen 200 ETF
占比0.48%
Inspire Small/Mid Cap ESG ETF
占比0.18%
iShares Micro-Cap ETF
占比0.05%
Federated Hermes MDT Small Cap Core ETF
占比0.05%
Fidelity Enhanced Small Cap ETF
占比0.03%
Invesco Nasdaq Biotechnology ETF
占比0.02%
iShares Biotechnology ETF
占比0.02%
ProShares Ultra Nasdaq Biotechnology
占比0.02%
iShares Russell 2000 ETF
占比0.01%
ProShares Hedge Replication ETF
占比0.01%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
